Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors

Launched by UNIVERSITY OF MEMPHIS · Mar 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a digital program called Aviva, designed to help prevent suicidal thoughts and behaviors in servicemembers who have recently experienced such feelings or attempts. The goal is to see if using Aviva on a smartphone can effectively reduce suicidal thoughts compared to standard care methods. Participants will be enrolled at primary care clinics at Fort Carson and will complete various assessments over a period of up to 12 months to track their progress.

To join the study, participants need to be at least 18 years old and have had suicidal thoughts in the past week or a suicide attempt in the last 30 days. They should also own a compatible smartphone. During the trial, participants will be randomly assigned to use either the Aviva program or a control method, which involves creating a safety plan and receiving standard mental health care. Those using Aviva will have weekly check-ins with research clinicians to support their treatment and address any concerns. The trial aims to enroll 720 participants over two years, and all data collected will be used to understand the program's effectiveness and improve future treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • at least 18 years old
• • suicidal ideation within the past week and/or a suicide attempt within the past 30 days
• • ability to complete the informed consent process
• • ownership of either an Apple iPhone iOS 11 or higher or an Android smartphone OS 8.1 or higher
• Exclusion Criteria:
• • an inability to complete informed consent procedures (e.g., acute intoxication, altered consciousness)
• • experiencing active psychosis or mania requiring hospitalization; (3) and inability to use a smartphone.